Precision Medicine: The Race to Integrate AI and Big Data Technologies Into Clinical Care Has Never Been More Important
An aging population worldwide with the associated prevalence of chronic diseases and late-life disabilities mandates greater emphasis on use of precision medicine in the clinical setting In 2015, when the Obama Administration announced the Precision Medicine Initiative, a research effort to revolutionize health and disease treatment, it heralded a shift in the traditional “one-size-fits-all” approach […]
CereMetrix on Forbes.com: Using Data Analytics to Fight the Opioid Crisis
The opioid crisis statistics are alarming: Drug overdoses, most of which are related to opioids, killed over 64,000 people in the United States last year — an increase of 21% over 2015. Disturbing as those numbers are, understanding the data behind opioid addiction, and analyzing the overwhelming information being collected is critical to fighting the drug crisis. In […]
CereScan’s Kelley to Share His Unique Insights Into Unlocking The Mysteries of The Human Brain as Panelist at Singularity University’s Global Forum
John Kelley, Chairman and CEO of CereScan®, will inject his inimitable style and passion for the plight of sufferers of chronic brain disorders when he addresses Singularity University’s Global Forum as a member of the Breakthrough Braintech Panel on August 15, 2017 in San Francisco. Kelley will join other innovators in discussing the connection between […]
Medical innovation and progress don’t have to stop under tight federal budgets
There has been a lot of discussion about Pres. Trump’s first budget submission, particularly in healthcare channels, leading to more questions than answers. Will Medicaid really be cut by billions of dollars? Are certain research programs and pharmaceutical regulations destined for the scrap heap? Will the CDC and NIH have their budgets slashed? The list […]
